Clinical trial
Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004
NCT00426101 · Karolinska University Hospital, Other · Completed
Key facts
| NCT number | NCT00426101 |
|---|---|
| Title | Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004 |
| Official title | HLH-2004 Treatment Protocol |
| Lead sponsor | Karolinska University Hospital, Other |
| Collaborators | Meyer Children's Hospital IRCCS Leiden University Medical Center Children's Hospital Medical Center, Cincinnati Ehime University Graduate School of Medicine Universitätsklinikum Hamburg-Eppendorf… |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hemophagocytic Lymphohistiocytosis |
| Intervention type | Drug, Procedure |
| Interventions | Dexamethasone, Etoposide, Cyclosporin, Intrathecal therapy, Stem cell transplant |
| Enrollment | 368 |
| Start date | Jan 1, 2004 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2017 |
| First posted | Jan 24, 2007 |
| Last update posted | Jul 5, 2018 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: